Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
International private equity firm, Cinven, has agreed to acquire Bioclinica, a global provider of clinical trial services and technology to contract research organizations (CROs) and pharmaceutical companies, based in Pennsylvania, from Water Street ...
read more
Tuesday, January 21, 2020
Cipher announced the Company received a Notice of Termination from Bausch Health in connection with the License, Development and Commercialization Agreement of Trulance.
read more
Cipla Limited announced its submission of an ANDA for Fluticasone propionate and Salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the FDA.
read more
Wednesday, March 03, 2021
Cipla has received final approval for its ANDA for Sumatriptan Nasal Spray, 20 mg from the FDA.
read more
Cipla has received final approval for its ANDA for Icatibant Injectable 30mg/3mL from the FDA.
read more
CiRA Foundation and the CGT Catapult are launching a new collaborative research project focused on induced pluripotent stem cell characterization.
read more
Cirrus Pharmaceuticals, a Kemwell company, has announced that Andrew Hamer has joined as VP R&D.
read more
Tuesday, February 09, 2016
Cirrus Pharmaceuticals, a Kemwell company, has announced that it is ready to launch its services for manufacturing cGMP materials for early phase clinical trials in its newly constructed state-of-the-art flexi-suite at its Raleigh-Durham, USA, site.
read more
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in ...
read more
Citoxlab Group has entered into a definitive agreement to acquire Solvo Biotechnology, a CRO specializing in drug transporter studies and the assessment of Drug-Drug Interactions.
read more
Tuesday, October 31, 2017
Citoxlab Group announces the acquisition of Xenometrics, an American CRO specialized in the non-clinical assessment of new drug candidates.
read more
Thursday, August 30, 2018
Citoxlab announces the hiring of Christophe Berthoux as CEO, Europe.
read more
CiVentiChem, a contract development and manufacturing organization (CDMO), announced the completion of a new facility, significantly expanding its manufacturing capacity by 300%. This state-of-the-art facility will focus on producing Regulatory ...
read more
Wednesday, January 22, 2020
Civica Rx has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
read more
Wednesday, December 18, 2019
Civica Rx and Hikma Pharmaceuticals announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines.
read more